Inhibiting SIRT1 in our HepG2 tumor cell system prior to resveratrol treatment resulted in a slightly decreased hyperacetylation of cellular proteins, which did not reach significance (Supplementary Figure S5A). Here, SIRT1 is linked to neoplasm.